Company Search:
Advanced Search
Sponsored Links
GW Pharmaceuticals PLC - ADR Company Snapshot
GW Pharmaceuticals PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares GW Pharmaceuticals PLC with three other companies in this sector in UNITED STATES : Radius Health Inc (2019 sales of $173.32 million of which 100% was Drug Manufacturer), Crispr Therapeutics AG ($289.59 million of which 100% was Biotechnology), and Luminex Corporation ($334.64 million of which 100% was ays related product).

Sales Analysis. Sales increased substantially in 2019: GW Pharmaceuticals PLC reported sales of $311.33 million for the year ending December of 2019. This represents an increase of 1,069.7% versus 2018, when the company's sales were $26.62 million.
  Stock Performance Chart for GW Pharmaceuticals PLC - ADR
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 127.63
(Figures in U.S. Dollars)
1 Week 1.2%   13 Weeks 1.8%  
4 Weeks 28.4%   52 Weeks -18.0%  
GW Pharmaceuticals PLC - ADR Key Data:
  Ticker: GWPH Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 311,332,341
(Year Ending Jan 2020).
Employees: 901
  Currency: U.S. Dollars Market Cap: 3,962,508,274
  Fiscal Yr Ends: December Shares Outstanding: 31,046,841
  Share Type: Common Closely Held Shares: 937,810
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.